Mendelspod

Mendelspod

Home
Archive
About
Can Math and AI Replace Some Biology in Drug Discovery? with Aridni Shah, Immunito AI
What if drug design didn’t depend on pre-existing biological data?
 • 
Theral Timpson
21:34
$10 Genome, $8 Coffee: Rethinking the Economics of Life Science Tools with Stephane Budel, DeciBio
Yes, the Trump economy has been tough on life science tools—but according to today’s guest, the business model was failing us anyway.
 • 
Theral Timpson
32:16
Quantum Scale: A New Era for Single-Cell Analysis with Giovanna Prout
On today’s episode of Mendelspod, Theral sits down with Giovanna Prout, CEO of Scale Biosciences, to explore a how the company is achieving new orders…
 • 
Theral Timpson
36:33
Building Intuition at the Nanoscale: Steve McCloskey of Nanome on the VR Future of Science
What if you could step inside a molecule? On today’s episode of Mendelspod, we talk with Steve McCloskey, founder and CEO of Nanome, the company…
 • 
Theral Timpson
42:06

April 2025

Beyond the $100 Genome--the Everyday Sequencing Revolution You Missed: Mark Budde, Plasmidsaurus
Wait! What? Sequencing as a service?That was the reaction when Mark Budde first set out to upend a basic ritual in molecular biology—confirmation Sanger…
 • 
Theral Timpson
36:40
What Next for LDTs? A Conversation with Sarah Overton of Velsera
Just weeks before the FDA’s sweeping rule to regulate laboratory-developed tests (LDTs) was set to take effect, a federal court struck it down.
 • 
Theral Timpson
37:49
AI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com
In today’s show, Theral is joined by Chris Petersen, Chief Technology Officer at Scientist.com, a company sometimes called the "Amazon for…
 • 
Theral Timpson
26:46
We've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude's
In today’s program, we continue our series on disease subtyping with Dr. Jeffery Klco, a pediatric pathologist and researcher at St. Jude Children’s…
 • 
Theral Timpson
25:24
Aaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer Research
Dr. Aaron Viny, oncologist and researcher at Columbia University, begins today’s conversation with a personal milestone—he’s now been leukemia-free for…
 • 
Theral Timpson
40:40
Toward Disease Sub-typing with Ben Busby, DNAnexus
We’re happy to welcome back Ben Busby, Principal Scientist at DNAnexus, to dive deeper into the evolving world of disease subtyping and multi-omic data…
 • 
Theral Timpson
29:32
Synthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John Cumbers
John Cumbers, founder of SynBioBeta, joins Theral for our annual look ahead at the field of synthetic biology and the upcoming SynBioBeta 2025…
 • 
Theral Timpson
37:35

March 2025

© 2025 Theral Timpson
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture